Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the ...

Adjusted operating margin is projected in the range of 6% to 8%, with net income per diluted share in the range of $1.23 to $1.81 and adjusted net income per diluted share in the range of $1.85 to ...

Kollam: Fourth additional district and sessions court in Kollam on Saturday adjourned further proceedings in Puttingal Devi Temple blast case to Feb 2.

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2025 Earnings Call Transcript February 12, 2026 Sensus Healthcare, Inc. misses on ...

SRT: Superficial Radiation Therapy, a low-energy radiation-based technology used for noninvasive skin cancer treatment. IGSRT ...

At this time, I would like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] I'll now hand the call over to your first ...

Management intentionally advised customers to pause system acquisitions in late 2025 until the new CMS codes were finalized, ensuring long-term trust and alignment with physician economics. Sensus is ...

Sensus Healthcare Inc (SRTS) outlines its path to profitability in 2026 amid revenue declines and increased international demand.

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Sensus Healthcare, Inc. , a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, ...

Driven by a growing patient population, rapid adoption of minimally invasive and robotic technologies, increased use of ...

For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and ...